TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Cytokine Modulators

Pharmaceutical products
Scotland (UKM)
Published value
Not published
Submission deadline Not published
Lots published8
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"): "Cytokine Modulators". Published status: complete. Published value: Value not published. 8 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
9.9Bids / Report
23.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 974 active published awards; 798 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Feb 2021, 08:56 GMT
Last source update11 Feb 2021, 08:56 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Scotland (UKM)
OCIDocds-h6vhtk-02923c
What is being bought
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.
What changed
From the official release history
  1. Status changed to complete
    11 Feb 2021, 08:56 GMT
  2. Official notice release published
    11 Feb 2021, 08:56 GMT
  3. Buyer information updated
    11 Feb 2021, 08:56 GMT
Lots and requirements (8)
Published by the contracting authority
  • Lot 1 · #1
    Etanercept
    cancelled
    Published valueNot published
    Supply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Infliximab IV
    cancelled
    Published valueNot published
    Supply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Infliximab Subcutaneous
    cancelled
    Published valueNot published
    Supply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Adalimumab
    cancelled
    Published valueNot published
    Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device
    cancelled
    Published valueNot published
    Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #6
    Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes
    cancelled
    Published valueNot published
    Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 7 · #7
    Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device
    cancelled
    Published valueNot published
    Supply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 8 · #8
    Methotrexate (25mg per 1 ml concentration ) pre-filled syringes
    cancelled
    Published valueNot published
    Supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Feb 2021, 08:56 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £46,271,726
  11. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £18,193,906
  12. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £307,680
  13. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £36,167,709
  14. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £14,775,961
  15. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £390,136
  16. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £218,102
  17. Contract active
    Signed 11 Jan 2021, 00:00 GMT · £317,995
Commercial outcome and competition
Awards
Biogen Idec Ltd., Pfizer Ltd, Sandoz Ltd
Not published · Not published · active
Biogen Idec Ltd., Celltrion Healthcare United Kingdom Limited, Merck Sharp & Dohme, Pfizer Ltd, Sandoz Ltd
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
AbbVie Ltd, Biogen Idec Ltd., Fresenius Kabi Limited, Sandoz Ltd, amgen ltd
Not published · Not published · active
Accord-UK Ltd, medac Pharma LLP
Not published · Not published · active
Accord UK Ltd
Not published · Not published · active
Nordic Pharma Ltd
Not published · Not published · active
Nordic Pharma Ltd
Not published · Not published · active
Contracts
Etanercept
£46,271,726 · signed 11 Jan 2021, 00:00 GMT · active
Infliximab IV
£18,193,906 · signed 11 Jan 2021, 00:00 GMT · active
Infliximab Subcutaneous
£307,680 · signed 11 Jan 2021, 00:00 GMT · active
Adalimumab
£36,167,709 · signed 11 Jan 2021, 00:00 GMT · active
Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device
£14,775,961 · signed 11 Jan 2021, 00:00 GMT · active
Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes
£390,136 · signed 11 Jan 2021, 00:00 GMT · active
Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device
£218,102 · signed 11 Jan 2021, 00:00 GMT · active
Methotrexate (25mg per 1 ml concentration ) pre-filled syringes
£317,995 · signed 11 Jan 2021, 00:00 GMT · active
Bid statistics
bids: 3 (lot 1)
electronicBids: 3 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 3 (lot 1)
smeBids: 0 (lot 1)
bids: 5 (lot 2)
electronicBids: 5 (lot 2)
foreignBidsFromEU: 0 (lot 2)
foreignBidsFromNonEU: 5 (lot 2)
smeBids: 1 (lot 2)
bids: 1 (lot 3)
electronicBids: 1 (lot 3)
foreignBidsFromEU: 0 (lot 3)
foreignBidsFromNonEU: 1 (lot 3)
smeBids: 1 (lot 3)
bids: 5 (lot 4)
electronicBids: 5 (lot 4)
foreignBidsFromEU: 0 (lot 4)
foreignBidsFromNonEU: 5 (lot 4)
smeBids: 0 (lot 4)
bids: 2 (lot 5)
electronicBids: 2 (lot 5)
foreignBidsFromEU: 0 (lot 5)
foreignBidsFromNonEU: 2 (lot 5)
smeBids: 1 (lot 5)
bids: 1 (lot 6)
electronicBids: 1 (lot 6)
foreignBidsFromEU: 0 (lot 6)
foreignBidsFromNonEU: 1 (lot 6)
smeBids: 0 (lot 6)
bids: 1 (lot 7)
electronicBids: 1 (lot 7)
foreignBidsFromEU: 0 (lot 7)
foreignBidsFromNonEU: 1 (lot 7)
smeBids: 1 (lot 7)
bids: 1 (lot 8)
electronicBids: 1 (lot 8)
foreignBidsFromEU: 0 (lot 8)
foreignBidsFromNonEU: 1 (lot 8)
smeBids: 1 (lot 8)
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authority GB-FTS-322
View buyer profile

  • The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
    buyer
    centralPurchasingBody

    Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    Nadia.Crockett@nhs.scot
    +44 1698794410

  • AbbVie Ltd
    supplier

    Abbvie House, Vanwall Business Park, Maidenhead, UKM, SL6 4UB

  • Accord UK Ltd
    supplier

    Whiddon Valley, Barnstaple, UKM, EX32 8NS

  • Accord-UK Ltd
    supplier

    Whiddon Valley, Barnstaple, UKM, EX32 8NS

  • Biogen Idec Ltd.
    supplier

    Innovation House, 70 Norden Road, Maidenhead, UKM, SL4 6AY

  • Celltrion Healthcare United Kingdom Limited
    supplier

    1-7 The Switch, Slough, UKM, SL1 1QP

  • Fresenius Kabi Limited
    supplier

    Cestrian Court, Eastgate Way, Manor Park, Runcorn, UKM, WA7 1NT

  • Merck Sharp & Dohme
    supplier

    Hertford Road, Hoddesdon, UKM, EN119BU

  • Nordic Pharma Ltd
    supplier

    Unit 3, Commerce Park, Brunel Road, Theale, UKM, RG7 4AB

  • Pfizer Ltd
    supplier

    Walton Oaks, Dorking Road, Surrey, Tadworth, UKM, KT20 7NS

  • Sandoz Ltd
    supplier

    Frimley Business Park, Frimley, Camberley, UKM, GU16 7SR

  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    edinburgh@scotcourts.gov.uk

  • amgen ltd
    supplier

    240 cambridge science parl, cambrdige, UKM, cb4 0wd

  • medac Pharma LLP
    supplier

    Scion House, Innovation Park, Stirling, UKM, FK9 4NF
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published